scholarly journals Urgent Procedure

2020 ◽  
Author(s):  
Keyword(s):  
Author(s):  
Yolanda Gómez Lugo

¿Pueden las Cámaras tramitar las iniciativas de reforma constitucional aplicando simultáneamente los procedimientos parlamentarios de reforma constitucional y procedimientos legislativos abreviados? Más específicamente, ¿puede considerarse que los métodos de lectura única y urgencia son procedimientos adecuados para tramitar la revisión de la Constitución? En el Auto 9/2012 el Tribunal Constitucional parece haberse decantado por la tesis de la simultaneidad procedimental, conforme a la cual los procedimientos de reforma constitucional podrían aplicarse transversalmente junto a las técnicas procedimentales de lectura única y de urgencia. Sin embargo, haciendo una interpretación sistemática de las normas constitucionales y parlamentarias que regulan el modo de producción legislativa, es posible deducir que dichas modalidades abreviadas actúan como límites procedimentales en la tramitación parlamentaria de la revisión de la Constitución.Can the Parliament process constitutional reform initiatives applying the procedures of constitutional reform and abbreviated legislative procedures simultaneously? More specifically, can it be considered that the method of single reading and the urgent procedure are adequate for processing the revision of the Constitution? In the decision ATC 9/2012 the Constitutional Court seems to have embraced the thesis of procedural simultaneity, according to which the procedures of constitutional reform could be applied transversally along with the legislative techniques of single reading and urgency. However, making a systematic interpretation of constitutional and parliamentary rules governing the lawmaking process, it might be argued that these kind of abbreviates procedures act as procedural limits in the parliamentary processing of the constitutional revision.


Author(s):  
Matthew Read ◽  
Christopher V. Maani

Bedside procedures in the ICU are an integral component of critical care medicine. Anesthesiologists who are assigned to the ICU must adapt principles of safe and effective anesthesia practice to this novel outside-of-the-operating-room environment. There are several reasons for surgical procedures to sometimes be performed at the bedside in the ICU, such as the avoidance of transporting unstable patients from the ICU to the OR, or the lack of adequate time to mobilize resources to perform an urgent procedure in the OR. Readiness of the entire ICU team is essential to avoid compromising care due to production pressure or lack of standards routine to the OR environment. This chapter discusses the types of procedures performed in the ICU and reviews the requirements of performing them successfully.


1993 ◽  
Vol 107 (11) ◽  
pp. 1061-1062
Author(s):  
J. W. Nicol ◽  
G. I. Stables ◽  
K. Mackenzie

AbstractWe present a patient with established histiocytosis who developed dysphagia, retching, regurgitation, hoarseness and stridor. These symptoms were managed with carbon dioxide laser vaporization, electively on three occasions, and once as an urgent procedure, while awaiting radiotherapy, to control her airway.Histiocytosis is a rare cause of a number of otolaryngological syndromes, but there has been no previous record of this disease causing laryngopharyngeal symptoms. This paper discusses the classification of histiocytosis, and describes our management of this rare and intriguing case.


2021 ◽  
Vol 14 (1) ◽  
pp. e235542
Author(s):  
Khalid Javeed Khan ◽  
Vishal Farid Raza

We describe a case of a middle-aged woman who presented with progressive jaundice and was suspected to have rebound choledocholithiasis, which was initially managed with balloon extraction through endoscopic retrograde cholangiopancreatography at her first presentation. Healthcare in Pakistan, like many other developing countries, is divided into public and private sectors. The public sector is not always completely free of cost. Patients seeking specialised care in the public sector may find lengthy waiting times for an urgent procedure due to a struggling system and a lack of specialists and technical expertise. Families of many patients find themselves facing ‘catastrophic healthcare expenditure’, an economic global health quandary much ignored.


2021 ◽  
pp. 152660282110164
Author(s):  
Marwan Youssef ◽  
Meera Gunaseelan

Objective To describe a novel technique to redirect a malrotated branch when treating a symptomatic juxtarenal aortic aneurysm using an off-the-shelf multibranched endograft. Technique A 75-year-old patient was admitted because of a symptomatic juxtarenal aortic aneurysm with a maximum diameter of 9.2 cm. The aneurysm showed no infrarenal neck. Because of his comorbidities, an endovascular repair using off-the-shelf multibranched endograft was considered as urgent procedure. During the deployment, the devise malrotated clockwise. The incorporation of the renal branches was performed successfully; however, the superior mesenteric artery (SMA) branch was malpositioned, so that the SMA could not be cannulated. Both celiac and SMA branches were simultaneously cannulated and snared outside of the endograft redirecting the malrotated SMA branch (a branch-to-branch through-and-through wire technique). Leaving the through-and-through wire in situ, the SMA could be intubated using parallel wire through the SMA branch. The final angiogram showed a good perfusion of the renovisceral vessels. The aneurysm was completely excluded. The patient was discharged into a rehabilitation facility 8 days later without complications. The 12-month follow-up period was uneventful. Conclusion A branch-to-branch through-and-through wire technique for branch repositioning is feasible and may present a bailout tool.


2019 ◽  
Vol 120 (01) ◽  
pp. 027-035 ◽  
Author(s):  
John Fanikos ◽  
Debra Murwin ◽  
Fredrik Gruenenfelder ◽  
Igor Tartakovsky ◽  
Lionel Riou França ◽  
...  

AbstractIdarucizumab was approved for the reversal of dabigatran in 2015. We investigated whether postapproval usage patterns of idarucizumab in a real-world setting reflect those observed in the pivotal trials. No safety or efficacy data were collected in this medical record-based observational study. RE-VECTO, a global postapproval, international, surveillance program, involved hospital pharmacies in countries where idarucizumab was licensed and dispensed (August 2016–June 2018). Characteristics of sites prescribing idarucizumab and of eligible patients (≥ 18 years old and receiving idarucizumab regardless of prior oral anticoagulant use), as well as idarucizumab utilization data, were collected and analyzed descriptively. Sixty-one sites enrolled 359 patients. Most pharmacies (85.2%) were centralized, and the median idarucizumab units stocked per hospital was 2.0 (interquartile range, 1.0–3.0). Almost three-quarters of patients were elderly (74.9% aged > 70 years), and only four (1.1%) had received idarucizumab before. Nearly all patients were treated with dabigatran (97.5%). There was a low frequency of unapproved dabigatran dosage regimens (3.3%). Life-threatening or uncontrolled bleeding was the most frequent indication for idarucizumab (57.7%), followed by emergency surgery/urgent procedure (35.9%). Of the life-threatening bleeding events, the most frequent were gastrointestinal tract (44.4%) and intracranial (38.6%). Most patients (95.0%) were given the full dose of two vials (2 × 2.5 g) of idarucizumab initially, and very few (1.7%) received a second dose. Of those patients requiring emergency or scheduled/planned surgery/procedures, 25.5% underwent gastrointestinal and/or abdominal surgery/procedures. Real-world usage patterns of idarucizumab provide valuable insights into emergency reversal strategies. Off-label use was minimal.


Author(s):  
Louisa Stone ◽  
Eileen Merriman ◽  
Gordon Royle ◽  
Merit Hanna ◽  
Henry Chan

Background The recommended dose of idarucizumab, the specific reversal agent for dabigatran etexilate, is 5g. However, published data showed biochemical reversal after an initial 2.5g dose. Objectives This study aims to retrospectively compare the clinical effectiveness of 2.5g and 5g doses of idarucizumab used in dabigatran reversal in three hospitals in Auckland, New Zealand. Methods All patients receiving idarucizumab for dabigatran reversal between 1st April 2016 and 31st December 2018 were included. The primary outcome was the likelihood of receiving a second dose of idarucizumab during the same admission. Secondary outcomes included normalisation of coagulation profiles; and 30-day thrombotic, bleeding and mortality rates. Results Of 329 patients included, 206 received an upfront 2.5g dose and 123 received a 5g dose. The median age was 78 years and median creatinine clearance was 50mL/min. Most patients (62.6%) required idarucizumab for an urgent procedure, while 37.4% presented with bleeding. A 2.5g dose was not associated with an increased rate of receiving a second dose (OR 0.686, 95% CI 0.225-2.090). A similar proportion of patients in each group achieved a normal APTT (73.8% vs 80.0%, p=0.464) and dTCT (95.9% vs 91.4%, p=0.379) following idarucizumab infusion. There was no increase in the rate of death (OR 0.602, 95% CI 0.292-1.239), thrombosis (OR 0.386, 95% CI 0.107-1.396) or bleeding (OR 0.96, 95% CI 0.27-3.33) in the 2.5g dose group compared to the 5g dose group. Conclusions An initial 2.5g dose of idarucizumab appears effective for dabigatran reversal in the real-world setting.


2009 ◽  
Vol 11 ◽  
pp. 1-13
Author(s):  
Allan Rosas

Abstract This chapter considers the ECJ procedure and, in particular, the length of time required for cases to be heard, especially in proceedings pertaining to the Area of Freedom, Security and Justice, an area in which the saying ‘justice delayed, justice denied’ has particular force. It examines in particular the new urgent procedure, conceived in order to enable the Court to decide a case falling under the Area of Freedom, Security and Justice within an expedited time-frame. It concludes that, while undue haste should be avoided, lengthy time-frames for court proceedings are more often than not a sign of poor case management. The Area of Freedom, Security and Justice provides a special incentive for the ECJ to be vigilant as regards the length of court proceedings.


Sign in / Sign up

Export Citation Format

Share Document